Client characteristics associated with desire for additional services at syringe exchange programs

ReferencesReferences

• Avert. 2019. Needle and syringe programmes (NSPS) for HIV prevention [online]. Retrieved March 17, 2021, from https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes
   Google Scholar
• Bachi, K., Sierra, S., Volkow, N. D., Goldstein, R. Z., & Alia-Klein, N. (2017). Is biological aging accelerated in drug addiction? Current Opinion in Behavioral Sciences, 13, 34–39. https://doi.org/10.1016/j.cobeha.2016.09.007
   PubMed Web of Science ®Google Scholar
• Bailey, H., Townsend, C., Cortina-Borja, M., & Thorne, C. (2011). Insufficient antiretroviral therapy in pregnancy: Missed opportunities for prevention of mother-to-child transmission of HIV in Europe. Antiviral Therapy, 16(6), 895–903. https://doi.org/10.3851/IMP1849
   PubMed Web of Science ®Google Scholar
• Bardwell, G., Strike, C., Mitra, S., Scheim, A., Barnaby, L., Altenberg, J., & Kerr, T. (2020). “That’s a double-edged sword”: Exploring the integration of supervised consumption services within community health centres in Toronto, Canada. Health & Place, 61, 102245. https://doi.org/10.1016/j.healthplace.2019.102245
   PubMed Web of Science ®Google Scholar
• Betts, K. S., Chan, G., McIlwraith, F., Dietze, P., Whittaker, E., Burns, L., & Alati, R. (2016). Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies. Addiction, 111(7), 1214–1223. https://doi.org/10.1111/add.13339
   PubMed Web of Science ®Google Scholar
• Burns, K. 2009. Women, harm, reduction, and HIV: Key findings from Azerbaijan, Georgia, Kyrgyzstan, Russia, and Ukraine [online]. Open Society Foundations. Retrieved December 8, 2020, from https://www.opensocietyfoundations.org/publications/women-harm-reduction-and-hiv-2#publications_download
   Google Scholar
• Burr, C. K., Storm, D. S., Hoyt, M. J., Dutton, L., Berezny, L., Allread, V., & Paul, S. (2014). Integrating health and prevention services in syringe access programs: A strategy to address unmet needs in a high-risk population. Public Health Reports, 129(1_suppl1), 26–32. https://doi.org/10.1177/00333549141291S105
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2019). Regional differences in the drugs most frequently involved in drug overdose deaths: United States, 2017 [online]. Retrieved January 13, 2021, from https://stacks.cdc.gov/view/cdc/82186
   Google Scholar
• Cioffi, C. C., & Seeley, J. (2021). Voluntary pregnancy screening at syringe exchanges: A feasibility study. Journal of Prevention and Health Promotion, 2(1), 57–80. https://doi.org/10.1177/263207702097336
   PubMedGoogle Scholar
• Des Jarlais, D. C., Nugent, A., Solberg, A., Feelemyer, J., Mermin, J., & Holtzman, D. (2015). Syringe service programs for persons who inject drugs in urban, suburban, and rural areas—United States, 2013. Morbidity and Mortality Weekly Report, 64(48), 1337–1341. https://doi.org/10.15585/mmwr.mm6448a3
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., … Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192–e1207. https://doi.org/10.1016/S2214-109X(17)30375-3
   Google Scholar
• Drug Abuse Warning Network. 2012. The DAWN report: Highlights of the 2010 drug abuse warning network (DAWN) findings on drug-related emergency department visits [online]. Retrieved December 8, 2020, from https://www.samhsa.gov/data/sites/default/files/DAWN096/DAWN096/SR096EDHighlights2010.htm
   Google Scholar
• El-Bassel, N., & Strathdee, S. A. (2015). Women who use or inject drugs: An action agenda for women-specific, multilevel, and combination HIV prevention and research. JAIDS Journal of Acquired Immune Deficiency Syndromes, 69(Suppl. 2), S182–S190. https://doi.org/10.1097/QAI.0000000000000628
   PubMed Web of Science ®Google Scholar
• Green, T. C., Martin, E. G., Bowman, S. E., Mann, M. R., & Beletsky, L. (2012). Life after the ban: An assessment of US syringe exchange programs’ attitudes about and early experiences with federal funding. American Journal of Public Health, 102(5), e9–e16. https://doi.org/10.2105/AJPH.2011.300595
   PubMedGoogle Scholar
• Harrell, P. T., Mancha, B. E., Petras, H., Trenz, R. C., & Latimer, W. W. (2012). Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors. Drug and Alcohol Dependence, 122(3), 220–227. https://doi.org/10.1016/j.drugalcdep.2011.10.001
   PubMed Web of Science ®Google Scholar
• Heil, S. H., Jones, H. E., Arria, A., Kaltenbach, K., Coyle, M., Fischer, G., Stine, S., Selby, P., & Martin, P. R. (2011). Unintended pregnancy in opioid-abusing women. Journal of Substance Abuse Treatment, 40(2), 199–202. https://doi.org/10.1016/j.jsat.2010.08.011
   PubMed Web of Science ®Google Scholar
• Heil, S. H., Melbostad, H. S., & Rey, C. N. (2019). Innovative approaches to reduce unintended pregnancy and improve access to contraception among women who use opioids. Preventive Medicine, 128, 105794. https://doi.org/10.1016/j.ypmed.2019.105794
   PubMed Web of Science ®Google Scholar
• Kuhlmann, A. S., Bergquist, E. P., Danjoint, D., & Wall, L. L. (2019). Unmet menstrual hygiene needs among low-income women. Obstetrics and Gynecology, 133(2), 238–244. https://doi.org/10.1097/AOG.0000000000003060
   PubMed Web of Science ®Google Scholar
• Lorvick, J., Browne, E. N., Lambdin, B. H., & Comfort, M. (2018). Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine. Addictive Behaviors, 85, 94–99. https://doi.org/10.1016/j.addbeh.2018.05.013
   PubMed Web of Science ®Google Scholar
• McClure, F. L., Niles, J. K., Kaufman, H. W., & Gudin, J. (2017). Concurrent use of opioids and benzodiazepines: Evaluation of prescription drug monitoring by a United States laboratory. Journal of Addiction Medicine, 11(6), 420–426. https://doi.org/10.1097/ADM.0000000000000354
   PubMed Web of Science ®Google Scholar
• McNeil, R., & Small, W. (2014). ‘Safer environment interventions’: A qualitative synthesis of the experiences and perceptions of people who inject drugs. Social Science & Medicine, 106, 151–158. https://doi.org/10.1016/j.socscimed.2014.01.051
   PubMed Web of Science ®Google Scholar
• Meacham, M. C., Rudolph, A. E., Strathdee, S. A., Rusch, M. L., Brouwer, K. C., Patterson, T. L., Vera, A., Rangel, G., & Roesch, S. C. (2015). Polydrug use and HIV risk among people who inject Heroin in Tijuana, Mexico: A latent class analysis. Substance Use & Misuse, 50(10), 1351–1359. https://doi.org/10.3109/10826084.2015.1013132
   PubMed Web of Science ®Google Scholar
• Merz, F. (2018). United nations office on drugs and crime: World drug report 2017. SIRIUS–Zeitschrift Für Strategische Analysen, 2(1), 85–86. https://doi.org/10.1515/sirius-2018-0016
   Google Scholar
• Moore, E., Han, J., Serio-Chapman, C., Mobley, C., Watson, C., & Terplan, M. (2012). Contraception and clean needles: Feasibility of combining mobile reproductive health and needle exchange services for female exotic dancers. American Journal of Public Health, 102(10), 1833–1836. https://doi.org/10.2105/AJPH.2012.300842
   PubMed Web of Science ®Google Scholar
• Nerlander, L. M., Hess, K. L., Rose, C. E., Sionean, C., Thorson, A., Broz, D., & Paz-Bailey, G. (2017). Exchange sex and HIV infection among women who inject drugs—20 US cities, 2009. Journal of Acquired Immune Deficiency Syndromes (1999), 75(Suppl 3), S333–S340. https://doi.org/10.1097/QAI.0000000000001408
   PubMedGoogle Scholar
• Oregon Health Authority. (2017a): Syringe services program: HIV prevention: State of Oregon [online]. Retrieved December 8, 2020, from https://www.oregon.gov/oha/PH/DISEASESCONDITIONS/HIVSTDVIRALHEPATITIS/HIVPREVENTION/Pages/ssp.aspx
   Google Scholar
• Oregon Health Authority. (2017b). Oregon Syringe Services Program (SSP) Guidance [online]. Retrieved December 8, 2020, from https://www.oregon.gov/oha/PH/DISEASESCONDITIONS/HIVSTDVIRALHEPATITIS/HIVPREVENTION/Documents/le9974_Oregon_SSP_Guidance_Apr2017.pdf
   Google Scholar
• Oregon Health Authority. (2019). Expanding harm reduction & syringe exchange service programming capacity in Oregon [online]. Retrieved January 13, 2021, from https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/HarmReduction/SSPManual/Oregon-SSP-Manual-Printable.pdf
   Google Scholar
• Patra, J., Fischer, B., Maksimowska, S., & Rehm, J. (2009). Profiling poly-substance use typologies in a multi-site cohort of illicit opioid and other drug users in Canada–a latent class analysis. Addiction Research & Theory, 17(2), 168–185. https://doi.org/10.1080/16066350802372827
   Web of Science ®Google Scholar
• Pinkham, S., Stoicescu, C., & Myers, B. (2012). Developing effective health interventions for women who inject drugs: Key areas and recommendations for program development and policy. Advances in Preventive Medicine, 2012, 269123. https://doi.org/10.1155/2012/269123
   Google Scholar
• R Core Team. (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing.
   Google Scholar
• Roberts, A., Mathers, B., & Degenhardt, L. (2010). Women who inject drugs: A review of their risks, experiences, and needs. National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney Australia.
   Google Scholar
• Sherman, S. G., German, D., Cheng, Y., Marks, M., & Bailey-Kloche, M. (2006). The evaluation of the JEWEL project: An innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. AIDS Care, 18(1), 1–11. https://doi.org/10.1080/09540120500101625
   PubMed Web of Science ®Google Scholar
• Stoicescu, C. 2014. The global state of harm reduction 2012: Towards an integrated response [online]. Harm Reduction International. Retrieved December 10, 2020, from https://www.hri.global/global-state-of-harm-reduction-2012
   Google Scholar
• Stone, R. (2015). Pregnant women and substance use: Fear, stigma, and barriers to care. Health & Justice, 3(1), 2. https://doi.org/10.1186/s40352-015-0015-5
   Google Scholar
• Sumpter, C., & Torondel, B. (2013). A systematic review of the health and social effects of menstrual hygiene management. PLOS ONE, 8(4), e62004. https://doi.org/10.1371/journal.pone.0062004
   PubMed Web of Science ®Google Scholar
• Taplin, S., & Mattick, R. P. (2015). The nature and extent of child protection involvement among heroin‐using mothers in treatment: High rates of reports, removals at birth and children in care. Drug and Alcohol Review, 34(1), 31–37. https://doi.org/10.1111/dar.12165
   PubMed Web of Science ®Google Scholar
• Teesson, M., Hall, W., Lynskey, M., & Degenhardt, L. (2000). Alcohol-and drug-use disorders in Australia: Implications of the national survey of mental health and wellbeing. Australian & New Zealand Journal of Psychiatry, 34(2), 206–213. https://doi.org/10.1080/j.1440-1614.2000.00715.x
   PubMed Web of Science ®Google Scholar
• Tschann, M., Wright, T., Lusk, H., Giorgio, W., Colon, A., & Kaneshiro, B. (2019). Understanding the Family Planning Needs of Female Participants in a Syringe Exchange Program: A Needs Assessment and Pilot Project. Journal of Addiction Medicine, 13(5), 366–371. https://doi.org/10.1097/ADM.0000000000000508
   PubMed Web of Science ®Google Scholar
• Valente, P. K., Bazzi, A. R., Childs, E., Salhaney, P., Earlywine, J., Olson, J., Biancarelli, D. L., Marshall, B. D. L., & Biello, K. B. (2020). Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast. International Journal of Drug Policy, 85, 102934. https://doi.org/10.1016/j.drugpo.2020.102934
   PubMed Web of Science ®Google Scholar
• VanHouten, J. P. (2019). Drug overdose deaths among women aged 30–64 years—United States, 1999–2017. MMWR. Morbidity and Mortality Weekly Report, 68(1), 1–5. https://doi.org/10.15585/mmwr.mm6801a1
   PubMed Web of Science ®Google Scholar
• Winkelman, T. N., Chang, V. W., & Binswanger, I. A. (2018). Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Network Open, 1(3), e180558–e180558. https://doi.org/10.1001/jamanetworkopen.2018.0558
   PubMed Web of Science ®Google Scholar
• Wodak, A., & Cooney, A. (2006). Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use & Misuse, 41(6–7), 777–813. https://doi.org/10.1080/10826080600669579
   PubMed Web of Science ®Google Scholar
• Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376(9738), 355–366. https://doi.org/10.1016/S0140-6736(10)60832-X
   PubMed Web of Science ®Google Scholar
• Zou, G. (2004). A modified Poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159(7), 702–706. https://doi.org/10.1093/aje/kwh090
   PubMed Web of Science ®Google Scholar